Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap1.05B
Enterprise Value855.94M
CLOV
(NASDAQ)Clover Health Investments, Corp.
$2.04-- (--)
Loading... - Market loading
Clover Health Investments (CLOV) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)0.59
Forward Price/Sales0.51
Price/Book (mrq)3.07
Price/Tangible Book (mrq)3.10
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue0.48
EV/Earnings-14.68
EV/EBITDA-26.01
EV/EBIT-24.79
EV/FCF-9.91
Stock Price
Current price, 52-week range, and moving averages
Current Price$2.04
1-Day Change0.99%
52-Week High$4.80
52-Week Low$2.01
52-Week Change-54.26%
YTD Change-15.35%
1-Year Change-53.74%
50-Day MA$2.45
200-Day MA$2.81
Avg Volume (30 day)4.27M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding512.74M
Book Value per Share$0.66
Net Cash per Share$0.37
FCF per Share$-0.17
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$3.70
Target Upside/Downside81.37%
Analyst ConsensusBuy
Analyst Count1
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin34.88%
EBITDA Margin (ttm)-1.86%
EBIT Margin (ttm)-1.95%
Operating Margin (ttm)-3.25%
Pretax Margin (ttm)-3.25%
Profit Margin (ttm)-3.29%
FCF Margin (ttm)-4.87%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)-17.11%
Return on Assets (ttm)-10.42%
Return on Invested Capital (ttm)-18.08%
Return on Capital Employed (ttm)-9.43%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue1.77B
Gross Profit618.66M
Operating Income-57.66M
Pretax Income-57.71M
Net Income-58.32M
EBITDA-32.91M
EBIT-34.52M
Diluted EPS$-0.11
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow-84.61M
Capital Expenditures1.76M
Free Cash Flow-86.38M
Growth Rates (YoY)
Year-over-year growth metrics
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)559.66M
Cash & Securities (mrq)190.06M
Net Cash (mrq)190.06M
Net Cash per Share$0.37
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)0.00
Working Capital (mrq)137.47M
Total Equity (mrq)340.93M
Book Value per Share$0.66
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)1.71
Quick Ratio (mrq)1.71
Debt/Equity (mrq)0.00
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Ex-Dividend DateAug 23, 2021
Pay DateAug 23, 2021
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield-5.58%
FCF Yield-8.26%
Buyback Yield0.53%
Total Shareholder Yield0.53%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score0.53
Piotroski F-Score3/9